Case: We present a case of a physical therapy-induced fracture of the proximal humerus, presumably caused by forceful shoulder flexion and external rotation, after reverse total shoulder arthroplasty (RTSA) in a 70-year-old woman with underlying osteopenia, systemic lupus erythematosus, long-term glucocorticoid use, and common variable immunodeficiency.
Conclusion: This case of a physical therapy-induced greater tuberosity fracture after RTSA presents an example of an early postoperative complication with no impact on eventual successful surgical outcomes. Special consideration should be given to tailor the postoperative rehabilitation after RTSA in patients with increased risk of fractures.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2106/JBJS.CC.20.00665 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Trajectory, interactions, and predictors of higher symptom burden during induction therapy for multiple myeloma.
J Patient Rep Outcomes
December 2024
Department of Symptom Research, Unit 1450, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Article Synopsis
- - The study aimed to track symptom severity in multiple myeloma (MM) patients during 16 weeks of induction therapy and identify factors that predict high symptom burden, which are often overlooked in clinical settings.
- - Researchers used a symptom inventory to categorize patients into groups with persistently high or low symptom severity, finding that severe symptoms included pain, muscle weakness, and fatigue, affecting patients' quality of life and emotional well-being.
- - Results indicated that 31% of patients experienced high-severity symptoms, with factors like baseline symptom scores and being female linked to worse outcomes, highlighting the need for better monitoring and support during therapy.
Lower leukocytes pretreatment as a possible risk factor for therapy-induced leukopenia in interferon-beta-treated patients with multiple sclerosis.
Ther Adv Neurol Disord
October 2024
Department of Neurology, Focus Program Translational Neuroscience, Rhine-Main Neuroscience Network, University Medical Center of the Johannes Gutenberg University Mainz, Langenbeckstrasse 1, Mainz 55131, Germany.
Background: Interferon-beta (IFN-β) still plays a fundamental role in immunomodulation of people with multiple sclerosis (MS) with low disease activity and in clinically isolated syndrome (CIS). In 2014, pegylated (PEG) interferon was licensed by the European Medicines Agency (EMA) for relapsing-remitting MS (RRMS), enabling a lower dosing frequency.
Objectives: Our retrospective study compares laboratory findings and adverse events between subcutaneous (sc.
Predictive factors and dose-response effect of rehabilitation for upper limb induced recovery after stroke: systematic review with proportional meta-analyses.
Physiotherapy
December 2024
Department of Biomedical and Neuromotor Sciences - DIBINEM, Alma Mater Studiorum Università di Bologna, Bologna, Italy; Unit of Occupational Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Article Synopsis
- The review analyzes predictive factors for motor recovery in stroke patients undergoing rehabilitation, focusing on what influences patient responses to treatment.
- Only 6% of the studied research examined these predictive factors, revealing that over 30 hours of therapy can lead to notable clinical improvements, especially through task-oriented approaches.
- Key indicators of recovery included the integrity of the corticospinal tract, preservation of arm function, and certain genetic markers, suggesting that rehabilitation strategies should consider these elements for better outcomes.
Increasing the tumour targeting of antitumour drugs through anlotinib-mediated modulation of the extracellular matrix and the RhoA/ROCK signalling pathway.
J Pharm Anal
August 2024
School of Life Science and Technology, China Pharmaceutical University, Nanjing, 211198, China.
Anlotinib has strong antiangiogenic effects and leads to vessel normalization. However, the "window period" characteristic in regulating vessel normalization by anlotinib cannot fully explain the long-term survival benefits achieved through combining it with other drugs. In this study, through RNA sequencing (RNA-seq) and label-free quantitative proteomics analysis, we discovered that anlotinib regulated the expression of components of the extracellular matrix (ECM), leading to a significant reduction in ECM stiffness.
View Article and Find Full Text PDFAuthor Correction: Therapy-induced secretion of spliceosomal components mediates pro-survival crosstalk between ovarian cancer cells.
Nat Commun
July 2024
Research Institute for Systems Biology and Medicine, Moscow, 117246, Russian Federation.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!